Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle
What this study shows
The original isolation of rapamycin from a soil bacterium found on Easter Island, discovered first as an antifungal compound decades before its mTOR-inhibiting mechanism was known.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Streptomyces hygroscopicus (soil bacterium)) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Streptomyces hygroscopicus (soil bacterium) |
| Journal | Journal of Antibiotics |
| Year | 1975 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.7164/antibiotics.28.721 · PMID 1102508 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Rapamycin (natural product isolation) |
| Target | Antifungal principle (later FKBP/TOR) |
| Model | Streptomyces hygroscopicus (soil bacterium) |
| Effect | Original isolation and characterization of rapamycin as an antifungal antibiotic from Easter Island soil |
In the Atlas
Related topics
Answers that reference this study
- Discussed in the plain-language answer What are mTOR inhibitors? The full list, by mechanism.
- Discussed in the plain-language answer What is mTOR?.
Was this page useful?
Thank you. Your answer was counted anonymously.